Health Immunovant Set to Release Q3 Earnings Amid Analyst Expectations Immunovant (NASDAQ: IMVT) is expected to announce its third-quarter earnings for 2026 before the market opens on February 6, 2026. Analysts project the company... Editorial17 hours ago